Journal of Experimental Medicine, Vol 179, 305-310, Copyright © 1994 by Rockefeller University Press

ARTICLES

Continuous administration of anti-interleukin 10 antibodies delays onset of autoimmunity in NZB/W F1 mice

H Ishida, T Muchamuel, S Sakaguchi, S Andrade, S Menon and M Howard
DNAX Research Institute, Palo Alto, California 94304.

We have previously shown that continuous administration of anti- interleukin 10 (anti-IL-10) antibodies (Abs) to BALB/c mice modifies endogenous levels of autoantibodies, tumor necrosis factor alpha (TNF- alpha), and interferon gamma, three immune mediators known to affect the development of autoimmunity in "lupus-prone" New Zealand black/white (NZB/W)F1 mice. To explore the consequences of IL-10 neutralization in NZB/W F1 mice, animals were injected two to three times per week from birth until 8-10 mo of age with anti-IL-10 Abs or with isotype control Abs. Anti-IL-10 treatment substantially delayed onset of autoimmunity in NZB/W F1 mice as monitored either by overall survival, or by development of proteinuria, glomerulonephritis, or autoantibodies. Survival at 9 mo was increased from 10 to 80% in anti- IL-10-treated mice relative to Ig isotype-treated controls. This protection against autoimmunity appeared to be due to an anti-IL-10- induced upregulation of endogenous TNF-alpha, since anti-IL-10- protected NZB/W F1 mice rapidly developed autoimmunity when neutralizing anti-TNF-alpha Abs were introduced at 30 wk along with the anti-IL-10 treatment. Consistent with the protective role of anti-IL-10 treatment in these experiments, continuous administration of IL-10 from 4 until 38 wk of age accelerated the onset of autoimmunity in NZB/W F1 mice. The same period of continuous IL-10 administration did not appear to be toxic to, or cause development of lupus-like autoimmunity in normal BALB/c mice. These data suggest that IL-10 antagonists may be beneficial in the treatment of human systemic lupus erythematosus.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Sharabi, A., Mozes, E. (2008). The Suppression of Murine Lupus by a Tolerogenic Peptide Involves Foxp3-Expressing CD8 Cells That Are Required for the Optimal Induction and Function of Foxp3-Expressing CD4 Cells. J. Immunol. 181: 3243-3251 [Abstract] [Full Text]  
• Scholz, J., Lukacs-Kornek, V., Engel, D. R., Specht, S., Kiss, E., Eitner, F., Floege, J., Groene, H.-J., Kurts, C. (2008). Renal Dendritic Cells Stimulate IL-10 Production and Attenuate Nephrotoxic Nephritis. J. Am. Soc. Nephrol. 19: 527-537 [Abstract] [Full Text]  
• Schiffer, L., Bethunaickan, R., Ramanujam, M., Huang, W., Schiffer, M., Tao, H., Madaio, M. M., Bottinger, E. P., Davidson, A. (2008). Activated Renal Macrophages Are Markers of Disease Onset and Disease Remission in Lupus Nephritis. J. Immunol. 180: 1938-1947 [Abstract] [Full Text]  
• Nakano, S., Morimoto, S., Suzuki, J., Nozawa, K., Amano, H., Tokano, Y., Takasaki, Y. (2008). Role of pathogenic auto-antibody production by Toll-like receptor 9 of B cells in active systemic lupus erythematosus. Rheumatology (Oxford) 47: 145-149 [Abstract] [Full Text]  
• e Brito, R.R.N., De Lorenzo, B.H.P., Xander, P., Godoy, L.C., Lopes, J.D., da Silva, N.P., Sampaio, S.C., Mariano, M. (2007). Role of distinct immune components in the radiation-induced abrogation of systemic lupus erythematosus development in mice. Lupus 16: 947-954 [Abstract]  
• Ostrowski, M., Vermeulen, M., Zabal, O., Zamorano, P. I., Sadir, A. M., Geffner, J. R., Lopez, O. J. (2007). The Early Protective Thymus-Independent Antibody Response to Foot-and-Mouth Disease Virus Is Mediated by Splenic CD9+ B Lymphocytes. J. Virol. 81: 9357-9367 [Abstract] [Full Text]  
• Chowdhary, V. R., Grande, J. P., Luthra, H. S., David, C. S. (2007). Characterization of haemorrhagic pulmonary capillaritis: another manifestation of Pristane-induced lupus. Rheumatology (Oxford) 46: 1405-1410 [Abstract] [Full Text]  
• Yamauchi, M., Hashimoto, M., Ichiyama, K., Yoshida, R., Hanada, T., Muta, T., Komune, S., Kobayashi, T., Yoshimura, A. (2007). Ifi202, an IFN-inducible candidate gene for lupus susceptibility in NZB/W F1 mice, is a positive regulator for NF-{kappa}B activation in dendritic cells. Int Immunol 0: dxm054v1- [Abstract] [Full Text]  
• Kokeny, G., Godo, M., Nagy, E., Kardos, M., Kotsch, K., Casalis, P., Bodor, C., Rosivall, L., Volk, H-D., Zenclussen, A.C., Hamar, P. (2007). Skin disease is prevented but nephritis is accelerated by multiple pregnancies in autoimmune MRL/LPR mice. Lupus 16: 465-477 [Abstract]  
• Shiroiwa, W., Tsukamoto, K., Ohtsuji, M., Lin, Q., Ida, A., Kodera, S., Ohtsuji, N., Nakamura, K., Tsurui, H., Kinoshita, K., Nishimura, H., Shirai, T., Hirose, S. (2007). IL-4R{alpha} polymorphism in regulation of IL-4 synthesis by T cells: implication in susceptibility to a subset of murine lupus. Int Immunol 19: 175-183 [Abstract] [Full Text]  
• Langer, S., Langnickel, D., Enghard, P., Undeutsch, R., Burmester, G. R., Hiepe, F., Radbruch, A., Riemekasten, G. (2007). The systemic and SmD183-119-autoantigen-specific cytokine memory of Th cells in SLE patients. Rheumatology (Oxford) 46: 238-245 [Abstract] [Full Text]  
• Bobe, P., Bonardelle, D., Benihoud, K., Opolon, P., Chelbi-Alix, M. K. (2006). Arsenic trioxide: a promising novel therapeutic agent for lymphoproliferative and autoimmune syndromes in MRL/lpr mice. Blood 108: 3967-3975 [Abstract] [Full Text]  
• Bergamo, P., Luongo, D., Maurano, F., Mazzarella, G., Stefanile, R., Rossi, M. (2006). Conjugated linoleic acid enhances glutathione synthesis and attenuates pathological signs in MRL/MpJ-Faslpr mice. J. Lipid Res. 47: 2382-2391 [Abstract] [Full Text]  
• Ripley, B J M, Goncalves, B, Isenberg, D A, Latchman, D S, Rahman, A (2005). Raised levels of interleukin 6 in systemic lupus erythematosus correlate with anaemia. Ann Rheum Dis 64: 849-853 [Abstract] [Full Text]  
• Yamauchi, T., Ishibashi, A., Shikata, K., Tokuhara, N., Seino, K.-i., Kobayashi, S., Nagai, M. (2005). Effect of E6060 [4-{5-[7-Fluoro-4-(trifluoromethyl)benzo[b]furan-2-yl]-1H-2-pyrrolyl}benzoic Acid], a Novel Subtype-Selective Retinoid, on Lupus-Like Nephritis in Female (NZBxNZW)F1 Mice. J. Pharmacol. Exp. Ther. 312: 938-944 [Abstract] [Full Text]  
• Aringer, M, Smolen, J S (2005). Cytokine expression in lupus kidneys. Lupus 14: 13-18 [Abstract]  
• Watanabe, H., Mamelak, A. J., Weiss, E., Wang, B., Freed, I., Brice, A. K., Wachtman, L., Gabrielson, K. L., Yokota, N., Hicklin, D. J., Kerbel, R. S., Haas, M., Sauder, D. N. (2005). Anti-Vascular Endothelial Growth Factor Receptor-2 Antibody Accelerates Renal Disease in the NZB/W F1 Murine Systemic Lupus Erythematosus Model. Clin. Cancer Res. 11: 407-409 [Full Text]  
• Riemekasten, G., Langnickel, D., Enghard, P., Undeutsch, R., Humrich, J., Ebling, F. M., Hocher, B., Humaljoki, T., Neumayer, H., Burmester, G.-R., Hahn, B. H., Radbruch, A., Hiepe, F. (2004). Intravenous Injection of a D1 Protein of the Smith Proteins Postpones Murine Lupus and Induces Type 1 Regulatory T Cells. J. Immunol. 173: 5835-5842 [Abstract] [Full Text]  
• Yurino, H., Ishikawa, S., Sato, T., Akadegawa, K., Ito, T., Ueha, S., Inadera, H., Matsushima, K. (2004). Endocrine Disruptors (Environmental Estrogens) Enhance Autoantibody Production by B1 Cells. Toxicol Sci 81: 139-147 [Abstract] [Full Text]  
• Nagayama, Y., Watanabe, K., Niwa, M., McLachlan, S. M., Rapoport, B. (2004). Schistosoma mansoni and {alpha}-Galactosylceramide: Prophylactic Effect of Th1 Immune Suppression in a Mouse Model of Graves' Hyperthyroidism. J. Immunol. 173: 2167-2173 [Abstract] [Full Text]  
• Chen, M., Aosai, F., Norose, K., Mun, H.-S., Ishikura, H., Hirose, S., Piao, L.-X., Fang, H., Yano, A. (2004). Toxoplasma gondii infection inhibits the development of lupus-like syndrome in autoimmune (New Zealand Black x New Zealand White) F1 mice. Int Immunol 16: 937-946 [Abstract] [Full Text]  
• Sharif, M. N., Tassiulas, I., Hu, Y., Mecklenbrauker, I., Tarakhovsky, A., Ivashkiv, L. B. (2004). IFN-{alpha} Priming Results in a Gain of Proinflammatory Function by IL-10: Implications for Systemic Lupus Erythematosus Pathogenesis. J. Immunol. 172: 6476-6481 [Abstract] [Full Text]  
• Schmidt, K N, Ouyang, W (2004). Targeting interferon-{alpha}: a promising approach for systemic lupus erythematosus therapy. Lupus 13: 348-352 [Abstract]  
• Ravirajan, C. T., Wang, Y., Matis, L. A., Papadaki, L., Griffiths, M. H., Latchman, D. S., Isenberg, D. A. (2004). Effect of neutralizing antibodies to IL-10 and C5 on the renal damage caused by a pathogenic human anti-dsDNA antibody. Rheumatology (Oxford) 43: 442-447 [Abstract] [Full Text]  
• Schwarz, A., Maeda, A., Wild, M. K., Kernebeck, K., Gross, N., Aragane, Y., Beissert, S., Vestweber, D., Schwarz, T. (2004). Ultraviolet Radiation-Induced Regulatory T Cells Not Only Inhibit the Induction but Can Suppress the Effector Phase of Contact Hypersensitivity. J. Immunol. 172: 1036-1043 [Abstract] [Full Text]  
• Whyburn, L. R., Halcomb, K. E., Contreras, C. M., Lowell, C. A., Witte, O. N., Satterthwaite, A. B. (2003). Reduced Dosage of Bruton's Tyrosine Kinase Uncouples B Cell Hyperresponsiveness from Autoimmunity in lyn-/- Mice. J. Immunol. 171: 1850-1858 [Abstract] [Full Text]  
• Jacob, C. O., Zang, S., Li, L., Ciobanu, V., Quismorio, F., Mizutani, A., Satoh, M., Koss, M. (2003). Pivotal Role of Stat4 and Stat6 in the Pathogenesis of the Lupus-Like Disease in the New Zealand Mixed 2328 Mice. J. Immunol. 171: 1564-1571 [Abstract] [Full Text]  
• Asadullah, K., Sterry, W., Volk, H. D. (2003). Interleukin-10 Therapy--Review of a New Approach. Pharmacol. Rev. 55: 241-269 [Abstract] [Full Text]  
• Kinoshita, K., Yoo, B.-S., Nozaki, Y., Sugiyama, M., Ikoma, S., Ohno, M., Funauchi, M., Kanamaru, A. (2003). Retinoic Acid Reduces Autoimmune Renal Injury and Increases Survival in NZB/W F1 Mice. J. Immunol. 170: 5793-5798 [Abstract] [Full Text]  
• Kashipaz, M R A., Huggins, M L, Lanyon, P, Robins, A, Powell, R J, Todd, I (2003). Assessment of Be1 and Be2 cells in systemic lupus erythematosus indicates elevated interleukin-10 producing CD5+ B cells. Lupus 12: 356-363 [Abstract]  
• Balabanian, K., Couderc, J., Bouchet-Delbos, L., Amara, A., Berrebi, D., Foussat, A., Baleux, F., Portier, A., Durand-Gasselin, I., Coffman, R. L., Galanaud, P., Peuchmaur, M., Emilie, D. (2003). Role of the Chemokine Stromal Cell-Derived Factor 1 in Autoantibody Production and Nephritis in Murine Lupus. J. Immunol. 170: 3392-3400 [Abstract] [Full Text]  
• Zinger, H., Eilat, E., Meshorer, A., Mozes, E. (2003). Peptides based on the complementarity-determining regions of a pathogenic autoantibody mitigate lupus manifestations of (NZB x NZW)F1 mice via active suppression. Int Immunol 15: 205-214 [Abstract] [Full Text]  
• Mageed, R A, Isenberg, D A (2002). Tumour necrosis factor alpha in systemic lupus erythematosus and anti-DNA autoantibody production. Lupus 11: 850-855 [Abstract]  
• Yin, Z., Bahtiyar, G., Zhang, N., Liu, L., Zhu, P., Robert, M. E., McNiff, J., Madaio, M. P., Craft, J. (2002). IL-10 Regulates Murine Lupus. J. Immunol. 169: 2148-2155 [Abstract] [Full Text]  
• Puliti, M., von Hunolstein, C., Verwaerde, C., Bistoni, F., Orefici, G., Tissi, L. (2002). Regulatory Role of Interleukin-10 in Experimental Group B Streptococcal Arthritis. Infect. Immun. 70: 2862-2868 [Abstract] [Full Text]  
• Wang, P.-L., Ohura, K. (2002). PORPHYROMONAS GINGIVALIS LIPOPOLYSACCHARIDE SIGNALING IN GINGIVAL FIBROBLASTS-CD14 AND TOLL-LIKE RECEPTORS. Crit. Rev. Oral Biol. Med. 13: 132-142 [Abstract] [Full Text]  
• Wang, P.-L., Ohura, K. (2002). PORPHYROMONAS GINGIVALIS LIPOPOLYSACCHARIDE SIGNALING IN GINGIVAL FIBROBLASTS-CD14 AND TOLL-LIKE RECEPTORS. fake Crit Rev Oral Biol Med 13: 132-142 [Abstract] [Full Text]  
• Balabanian, K., Foussat, A., Bouchet-Delbos, L., Couderc, J., Krzysiek, R., Amara, A., Baleux, F., Portier, A., Galanaud, P., Emilie, D. (2002). Interleukin-10 modulates the sensitivity of peritoneal B lymphocytes to chemokines with opposite effects on stromal cell-derived factor-1 and B-lymphocyte chemoattractant. Blood 99: 427-436 [Abstract] [Full Text]  
• Jolly, C. A., Muthukumar, A., Avula, C. P. R., Troyer, D., Fernandes, G. (2001). Life Span Is Prolonged in Food-Restricted Autoimmune-Prone (NZB NZW)F(1) Mice Fed a Diet Enriched with (n-3) Fatty Acids. J. Nutr. 131: 2753-2760 [Abstract] [Full Text]  
• Hahn, B H (2001). Lessons in lupus: the mighty mouse. Lupus 10: 589-593  
• Dokka, S., Shi, X., Leonard, S., Wang, L., Castranova, V., Rojanasakul, Y. (2001). Interleukin-10-mediated inhibition of free radical generation in macrophages. Am. J. Physiol. Lung Cell. Mol. Physiol. 280: L1196-L1202 [Abstract] [Full Text]  
• Lopatin, U., Yao, X., Williams, R. K., Bleesing, J. J. H., Dale, J. K., Wong, D., Teruya-Feldstein, J., Fritz, S., Morrow, M. R., Fuss, I., Sneller, M. C., Raffeld, M., Fleisher, T. A., Puck, J. M., Strober, W., Jaffe, E. S., Straus, S. E. (2001). Increases in circulating and lymphoid tissue interleukin-10 in autoimmune lymphoproliferative syndrome are associated with disease expression. Blood 97: 3161-3170 [Abstract] [Full Text]  
• Isomaki, P., Panesar, M., Annenkov, A., Clark, J. M., Foxwell, B. M. J., Chernajovsky, Y., Cope, A. P. (2001). Prolonged Exposure of T Cells to TNF Down-Regulates TCR{{zeta}} and Expression of the TCR/CD3 Complex at the Cell Surface. J. Immunol. 166: 5495-5507 [Abstract] [Full Text]  
• Strand, V (2001). Monoclonal antibodies and other biologic therapies. Lupus 10: 216-221 [Abstract]  
• Daikh, D. I., Wofsy, D. (2001). Cutting Edge: Reversal of Murine Lupus Nephritis with CTLA4Ig and Cyclophosphamide. J. Immunol. 166: 2913-2916 [Abstract] [Full Text]  
• Kim, U., Gunther, C. S., Roeder, R. G. (2000). Genetic Analyses of NFKB1 and OCA-B Function: Defects in B Cells, Serum IgM Level, and Antibody Responses in Nfkb1-/-Oca-b-/- Mice. J. Immunol. 165: 6825-6832 [Abstract] [Full Text]  
• Dokka, S., Malanga, C. J., Shi, X., Chen, F., Castranova, V., Rojanasakul, Y. (2000). Inhibition of endotoxin-induced lung inflammation by interleukin-10 gene transfer in mice. Am. J. Physiol. Lung Cell. Mol. Physiol. 279: L872-L877 [Abstract] [Full Text]  
• Balasa, B., Van Gunst, K., Jung, N., Balakrishna, D., Santamaria, P., Hanafusa, T., Itoh, N., Sarvetnick, N. (2000). Islet-Specific Expression of IL-10 Promotes Diabetes in Nonobese Diabetic Mice Independent of Fas, Perforin, TNF Receptor-1, and TNF Receptor-2 Molecules. J. Immunol. 165: 2841-2849 [Abstract] [Full Text]  
• Gunnarsson, I., Nordmark, B., Hassan Bakri, A., Grondal, G., Larsson, P., Forslid, J., Klareskog, L., Ringertz, B. (2000). Development of lupus-related side-effects in patients with early RA during sulphasalazine treatment--the role of IL-10 and HLA. Rheumatology (Oxford) 39: 886-893 [Abstract] [Full Text]  
• Venkatraman, J. T., Chu, W.-c. (1999). Effects of Dietary {omega}-3 and {omega}-6 Lipids and Vitamin E on Serum Cytokines, Lipid Mediators and Anti-DNA Antibodies in a Mouse Model for Rheumatoid Arthritis. J. Am. Coll. Nutr. 18: 602-613 [Abstract] [Full Text]  
• Zavala, F., Masson, A., Hadaya, K., Ezine, S., Schneider, E., Babin, O., Bach, J.-F. (1999). Granulocyte-Colony Stimulating Factor Treatment of Lupus Autoimmune Disease in MRL-lpr/lpr Mice. J. Immunol. 163: 5125-5132 [Abstract] [Full Text]  
• Nakashima, H., Akahoshi, M., Tanaka, Y., Yamaoka, K., Ogami, E., Nagano, S., Arinobu, Y., Niiro, H., Otsuka, T., Niho, Y. (1999). Polymorphisms within the interleukin-10 receptor cDNA gene (IL10R) in Japanese patients with systemic lupus erythematosus. Rheumatology (Oxford) 38: 1142-1144 [Abstract] [Full Text]  
• Nishio, R., Matsumori, A., Shioi, T., Ishida, H., Sasayama, S. (1999). Treatment of Experimental Viral Myocarditis With Interleukin-10. Circulation 100: 1102-1108 [Abstract] [Full Text]  
• Saito, I., Haruta, K., Shimuta, M., Inoue, H., Sakurai, H., Yamada, K., Ishimaru, N., Higashiyama, H., Sumida, T., Ishida, H., Suda, T., Noda, T., Hayashi, Y., Tsubota, K. (1999). Fas Ligand-Mediated Exocrinopathy Resembling Sjogren's Syndrome in Mice Transgenic for IL-10. J. Immunol. 162: 2488-2494 [Abstract] [Full Text]  
• Illei, G G, Klippel, J H (1998). Novel approaches in the treatment of lupus nephritis. Lupus 7: 644-648 [Abstract]  
• Wither, J., Vukusic, B. (1998). Autoimmunity Develops in Lupus-Prone NZB Mice Despite Normal T Cell Tolerance. J. Immunol. 161: 4555-4562 [Abstract] [Full Text]  
• Gilkeson, G. S., Conover, J., Halpern, M., Pisetsky, D. S., Feagin, A., Klinman, D. M. (1998). Effects of Bacterial DNA on Cytokine Production by (NZB/NZW)F1 Mice. J. Immunol. 161: 3890-3895 [Abstract] [Full Text]  
• Amital, H, Levi, Y, Blank, M, Barak, V, Langevitz, P, Afek, A, Nicoletti, F, Kopolovic, J, Gilburd, B, Meroni, P L, Shoenfeld, Y (1998). Immunomodulation of murine experimental SLE-like disease by interferon-{gamma}. Lupus 7: 445-454 [Abstract]  
• Lauwerys, B R, Houssiau, F A (1998). Cytokines: clues to the pathogenesis of SLE. Lupus 7: 211-213  
• Haas, C., Ryffel, B., Le Hir, M. (1998). IFN-{gamma} Receptor Deletion Prevents Autoantibody Production and Glomerulonephritis in Lupus-Prone (NZB NZW)F1 Mice. J. Immunol. 160: 3713-3718 [Abstract] [Full Text]  
• Zeng, D., Dick, M., Cheng, L., Amano, M., Dejbakhsh-Jones, S., Huie, P., Sibley, R., Strober, S. (1998). Subsets of Transgenic T Cells That Recognize CD1 Induce or Prevent Murine Lupus: Role of Cytokines. JEM 187: 525-536 [Abstract] [Full Text]  
• Clynes, R., Dumitru, C., Ravetch, J. V. (1998). Uncoupling of Immune Complex Formation and Kidney Damage in Autoimmune Glomerulonephritis. Science 279: 1052-1054 [Abstract] [Full Text]  
• Peng, S. L., Moslehi, J., Robert, M. E., Craft, J. (1998). Perforin Protects Against Autoimmunity in Lupus-Prone Mice. J. Immunol. 160: 652-660 [Abstract] [Full Text]  
• Cope, A. P., Liblau, R. S., Yang, X.-D., Congia, M., Laudanna, C., Schreiber, R. D., Probert, L., Kollias, G., McDevitt, H. O. (1997). Chronic Tumor Necrosis Factor Alters T Cell Responses by Attenuating T Cell Receptor Signaling. JEM 185: 1573-1584 [Abstract] [Full Text]  
• Santiago, M.-L., Fossati, L., Jacquet, C., Muller, W., Izui, S., Reininger, L. (1997). Interleukin-4 Protects against a Genetically Linked Lupus-like Autoimmune Syndrome. JEM 185: 65-70 [Abstract] [Full Text]  
• Barcellini, W., Rizzardi, G., Borghi, M., Nicoletti, F., Fain, C., Del Papa, N., Meroni, P. (1996). In vitro type-1 and type-2 cytokine production in systemic lupus erythematosus: lack of relationship with clinical disease activity. Lupus 5: 139-145 [Abstract]  
• Houssiau, F., Lefebvre, C., Vanden Berghe, M., Lambert, M., Devogelaer, J-P., Renauld, J-C. (1995). Serum interleukin 10 titers in systemic lupus erythematosus reflect disease activity. Lupus 4: 393-395 [Abstract]  

Home | Help | Feedback | Subscriptions | Archive | Search

TABLE OF CONTENTS